Large Volume Wearable Injectors Market Share

The North American large-volume wearable injectors market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the rising cases of chronic disease in the region. Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. They are also the leading drivers of the nation’s USD 4.1 trillion in annual healthcare costs. Further, the boom in the healthcare industry is another growth factor for the large volume of wearable injectors market growth. The revenue generated by the U.S. healthcare industry stood at USD 800 billion as of 2021. Additionally, the growing geriatric population in the region with severe autoimmune and chronic diseases is further anticipated to propel the market growth over the forecast period. It was projected that in the United States, every 6 people out of 10 suffer from at least 1 chronic disease.

Additionally, the global large-volume wearable injectors market is anticipated to hold the second-largest share in the Asia Pacific region over the forecast period. The growth of the market in the region can ascribe a higher prevalence of cancer in the region backed by the escalating spending capacity of the population coupled with an escalation in autoimmune diseases. For instance, in 2018, approximately 8 million new cases of cancer were diagnosed in Asia Pacific while more than 5 million death occurred owing to cancer in a similar year. Furthermore, the surge in the cases of diabetes, lung diseases, and others is further estimated to expand the market size over the forecast period.